The search for effective dementia prevention continues to challenge medical researchers worldwide. Now, a major study published in JAMA Neurology reveals that certain medications used to treat type 2 ...
A new Northwestern Medicine study has shed light on how a class of diabetes drugs may protect the kidneys—not just by lowering blood sugar, but by triggering a molecular shift that dampens ...
MedPage Today on MSN
Diabetes drug class tied to lower dementia risk in people with psych disorders
SGLT2 inhibitor use also correlated with lower rates of psychiatric ED visits ...
GLP-1 receptor agonists, a class of drug used to treat type 2 diabetes, likely trump the widely prescribed metformin for curbing dementia risk in people with the condition, finds the largest study of ...
When diabetes causes CKD, it’s sometimes called diabetic kidney disease. Elevated blood sugar levels that result from diabetes can damage the tiny blood vessels inside your kidneys. As a result, your ...
May 22 (Reuters) - Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's (NOVOb.CO), opens new tab Ozempic may modestly reduce the risk of obesity-related cancers, especially colorectal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results